Standout Papers
- Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. (2018)
Immediate Impact
2 from Science/Nature 65 standout
Citing Papers
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Works of Ting Xu being referenced
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ting Xu | 154 | 141 | 355 | 315 | 57 | 850 | |
| Jinming Wang | 59 | 107 | 71 | 78 | 57 | 698 | |
| Bingkun Chen | 56 | 55 | 80 | 24 | 34 | 803 | |
| Ting Zhang | 35 | 10 | 102 | 100 | 57 | 914 | |
| Wenting Tang | 65 | 82 | 73 | 90 | 71 | 663 | |
| Jie Cai | 32 | 52 | 44 | 37 | 53 | 826 | |
| Fen Zhao | 41 | 7 | 216 | 120 | 57 | 813 | |
| Chengbin Ma | 15 | 59 | 74 | 118 | 42 | 836 | |
| Jinsong Yang | 10 | 7 | 141 | 49 | 48 | 732 | |
| Fatemeh Tavakkoli | 52 | 35 | 120 | 62 | 36 | 823 | |
| Haiqiang Zhang | 94 | 13 | 105 | 35 | 62 | 962 |
All Works
Login with ORCID to disown or claim papers
Loading papers...